Industries > Pharma > Botanical and Plant-Derived Drugs Market Forecast to 2027

Botanical and Plant-Derived Drugs Market Forecast to 2027

Prospects for Leading Companies in Steroids, Phenols, Terpenes, Glycosides and Others, Sativex, Marinol Nabilone, Dexanabinol, CT-3, Cannabinor, HU 308, HU 331, Rimonabant, Taranabant

PUBLISHED: 19 December 2017
PAGES: 164
PRODUCT CODE: PHA0270

Clear
WOOCS 2.2.1

The global botanical and plant-derived drugs market is expected to grow at a CAGR of 6.8% in the first half of the forecast period. In 2016, the phenols submarket held 30.2% of the global botanical and plant-derived drugs market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 164-page report you will receive 70 tables and 82 figures– all unavailable elsewhere.

The 164-page report provides clear detailed insight into the global botanical and plant-derived drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Botanical and Plant-derived Drugs Market forecast to 2027

• This report also breaks down the revenue forecast for global botanical and plant-derived drugs market by type:
– Steroids
– Phenols
– Terpenes
– Glycosides
– Others

This report provides a SWOT analysis for each submarket.

Botanical and Plant-Derived Drugs Market Forecast to 2027

• This report also breaks down the revenue forecast for global botanical and plant-derived drugs market by application:
– Hormone Diseases
– Infectious Diseases
– Pain & Central Nervous System Disorders
– Cardiovascular & Metabolic Diseases
– Respiratory & Oncology Diseases

• Our work also shows individual revenue forecasts to 2027 for these regional and national markets
– North America: US & Canada
– Europe: Germany, France, the UK, Italy, Spain, Rest of Europe
– Asia-Pacific: China, Japan, India, Rest of APAC
– Latin America: Brazil, Mexico, Rest of Latin America
– Middle East & Africa: Saudi Arabia, South Africa, Rest of Middle East & Africa

Each regional market if further segmented by type and by application.

• This report discusses several brands, including:
– Sativex (GW Pharmaceuticals)
– Marinol (Unimed Pharmaceuticals)
– Nabilone / Cesamet (Valeant Pharmaceuticals)
– Dexanabinol (Solvay Pharmaceuticals, acquire by Abbott Laboratories)
– CT-3 (Indevus Pharmaceuticals)
– Cannabinor (Pharmos)
– HU 308 (Pharmos)
– HU 331 (Cayman Chemical)
– Rimonabant / Acomplia (Sanofi-Aventis)
– Taranabant / MK-0364 (Merck & Co.)

• This report assesses several leading companies that manufacture and market botanical and plant-derived drugs, including:
– Abbott Laboratories
– Bayer AG
– Eli Lilly
– Johnson & Johnson
– Novartis AG
– Pfizer, Inc.
– Bristol-Myers Squibb (BMS)
– Medigene AG

• This report also discusses the Drivers and Restraints of the global botanical and plat derived-drugs market.

Visiongain’s study is for everybody needing commercial analyses for the global botanical and plat derived-drugs market. You will find data, trends and predictions. Please order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Botanical and Plant-Derived Drugs Market Forecast to 2027


Download sample pages

Complete the form below to download your free sample pages for Botanical and Plant-Derived Drugs Market Forecast to 2027


Latest Pharma news

Visiongain Publishes Plasma Therapy Market Report 2021-2031

The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.

26 November 2020

READ

Visiongain Publishes Precision Cancer Diagnostic Test Market Report 2021-2031

Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.

26 November 2020

READ

Visiongain Publishes Top 50 Biosimilar Drug Manufacturers 2021

Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.

25 November 2020

READ

Visiongain Publishes Advanced Therapy Medicinal Products (ATMP) Market Report 2021-2031

Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth

24 November 2020

READ

Categories

Category